FILING ANALYSIS · WEDNESDAY, NOVEMBER 4
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL — 8-K: Results of Operations and Financial Condition
positive
Charles River Laboratories reported a strong third quarter with organic revenue growth of 4.7%, outperforming prior outlook, and increased guidance for revenue and non-GAAP earnings per share, driven by better-than-expected performance in the DSA segment and a lower tax rate.
The filing
8-K - CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (0001100682) (Filer)
How we read impact: we grade every directional call in the open. Impact labels are AI estimates — not investment advice. See the full disclaimer.
Get filings like this every market day
The US SEC filings, UK RNS, EU notices, and Polymarket odds that matter — scored by AI, in one email.
Subscribe free →